Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20150485Phase 3Completed
A Phase 3 trial of biphasic human insulin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Hefei Tianhui Biotechnology. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20150485.